How to prioritise active ingredients for a supplement brief

It's easy to plan an active's delivery form in the abstract — fat-soluble actives suit an oil-based carrier, water-soluble actives suit an aqueous one — without checking which of those carriers is actually a commercially available format today. Within DAT's six sellable formats (gummies, sachets, functional jellies, oral strips, liquid drops, pet soft chews), fat-soluble actives are commonly carried in liquid drops — vitamin D3, A, E and K2 drops all exist in the catalogue today — as well as in gummies, while water-soluble actives sit comfortably across gummies, sachets and functional jellies.

Checking format fit before finalising your active list avoids a brief that specifies an active-format pairing the current catalogue doesn't support — better to know that during the brief stage than after a first sample comes back needing a format change.

Multi-active formulas already exist across the catalogue — combining, for example, several vitamins in one gummy or drop is standard practice, not a stretch request. What changes as you add actives is formulation complexity: each additional active interacts with taste masking, stability and (for gummies and jellies) set texture, so a brief with two or three complementary actives is usually a smoother path to a fast sample approval than one that stacks many actives with competing flavour or stability profiles.

If your positioning calls for a longer active list, it's worth discussing formulation feasibility with your manufacturer before finalising the brief — the sooner a potential stability or taste conflict is flagged, the less it costs you in sample-round iteration later.

If you're briefing more than one SKU, prioritisation isn't only about which actives go into a single formula — it's also about which SKU launches first. A brief built around an active with an existing catalogue formulation (lower formulation risk, faster sample turnaround) is a reasonable first SKU, with a more novel active-format combination sequenced as a second SKU once you have a working relationship and documentation pattern established with the manufacturer.

This sequencing logic applies whether your range spans one format or several — see how to plan a multi-format supplement range for the format side of the same planning exercise.

Two brief details cause more back-and-forth than any others: an active list that names an ingredient without confirming it's permitted in the destination market, and an active-format pairing that hasn't been checked against the catalogue's existing sellable formats. Both are catchable before the brief goes to the manufacturer — a quick market-compliance check on each active, and a check against which formats already carry similar actives, saves a sample round.

A brief that names your priority actives clearly, in order, alongside your intended format, gives the manufacturer's team the clearest starting point for a feasibility response — vague briefs tend to come back with clarifying questions before formulation work can even start.

A brief is easier for a manufacturer to respond to quickly when your active list is ranked, not just listed — note which actives are non-negotiable to your positioning and which are flexible if a format or stability conflict comes up during formulation. This single distinction (must-have versus flexible) is often the difference between a fast first-round sample and a round spent going back and forth on which actives can be adjusted.

Pair the ranked list with your intended format and target market in the same document — the manufacturer's feasibility review checks active, format and market permissibility together, so a brief that presents all three at once moves through that review faster than one that arrives piecemeal.